We thank all investigators and consortiums for sharing valuable summary data
Mastroberardino Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Do not use Wegovy, Ozempic, Zepbound, or Compounded Liraglutide + B12 if you are currently pregnant, breastfeeding, or plan to become pregnant or breastfeed
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial